Evidence map›Paper›PMID 31639040›Full record

ArticleClinical epigenetics2019

Correction to: DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.

Malgorzata Pienkowska, Sanaa Choufani, Andrei L Turinsky, Tanya Guha, Diana M Merino, Ana Novokmet, Michael Brudno, Rosanna Weksberg, Adam Shlien, Cynthia Hawkins and 10 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical epigenetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Malgorzata PienkowskaGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Sanaa ChoufaniGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Andrei L TurinskyGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Tanya GuhaGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Diana M MerinoFriends of Cancer Research, 1800 M Street, NW, Suite 1050 South, Washington, DC, 20036, USA.
Ana NovokmetGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Michael BrudnoGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Rosanna WeksbergGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Adam ShlienGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Cynthia HawkinsGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Eric BouffetDivision of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.
Uri TaboriGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.
Richard J GilbertsonDepartment of Oncology, Cambridge Cancer Center, Robinson Way, Cambridge, CB2 0RE, England.
Jonathan L FinlayNeuro-Oncology Program, Nationwide Children's Hospital and The Ohio State University, 700 Children's Dr, Columbus, OH, 43205, USA.
Nada JabadoDivision of Hematology/Oncology, Montreal Children's Hospital of the McGill University Health Centre (RI-MUHC), 1001, Decarie Blvd, Montreal, Québec, H4A 3 J1, Canada.
Christian ThomasInstitute of Neuropathology, University Hospital Münster, 48149, Münster, Germany.
Martin SillHopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
David CapperDepartment of Neuropathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Martin HasselblattInstitute of Neuropathology, University Hospital Münster, 48149, Münster, Germany.
David MalkinGenetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada. david.malkin@sickkids.ca.

Funding

Cancer Research UK 22492
6 · The paper itself

Abstract

After publication of the original article [1], authors have requested to add a 'J' as middle name for Richard Gilbertson. Hence, full name should be Richard J Gilbertson.

Identifiers

PMID31639040
PMCPMC6802296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.